SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that Drs. JY Gaubert, P Chevallier, and V Vidal, leading French researchers, presented the successful results of their animal study utilizing the MicroThermX® Microwave Ablation System (MicroThermX) at CIRSE 2014. The study was sponsored by Terumo Europe N.V. The objective of the study was to determine reproducibility of the ablation volumes in liver and lung animal studies using the MicroThermX. The researchers examined the results of 18 liver ablations and 24 lung ablations and concluded that ablation volumes generated with the MicroThermX were reproducible in in-vivo liver and lung tissues.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
